Point-of-care testing for coeliac disease: Primary care diagnostic technology update

British Journal of General Practice

Volumn 63, Issue 611, 2013, Pages

  Khangura, Jaspreet ^a   Van Den Bruel, Ann ^a   Perera, Rafael ^a   Heneghan, Carl ^b   Price, Christopher P ^b   Wolstenholme, Jane ^b   Thompson, Matthew ^b   Plüddemann, Annette ^b  

^a University Lecturer and Medical Statistics   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ARTICLE; CELIAC DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DUODENUM BIOPSY; HUMAN; LABORATORY DEVICE; POINT OF CARE TESTING; PRACTICE GUIDELINE; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; SEROLOGY;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CELIAC DISEASE; COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MALE; MASS SCREENING; POINT-OF-CARE SYSTEMS; PREVALENCE; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TRANSGLUTAMINASES;

EID: 84878469484     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp13X668401     Document Type: Article

References (12)

1. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357(17): 1731-;1743.
2. National Institute for Health and Care Clinical Excellence. Coeliac disease: recognition and assessment of coeliac disease. CG86. London: NICE, 2009.
3. Gray AM, Papanicolas IN. Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res. 2010; 10: 105.
4. Nemec G, Ventura A, Stefano M, et al. Looking for celiac disease: diagnostic accuracy of two rapid commercial assays. Am J Gastroenterol 2006; 101(7): 1597-;1600.
5. Raivio T, Kaukinen K, Nemes E, et al. Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther 2006; 24(1): 147-;154.
6. Raivio T, Korponay-Szabo IR, Collin P, et al. Performance of a new rapid whole blood coeliac test in adult patients with low prevalence of endomysial antibodies. Dig Liver Dis 2007; 39(12): 1057-;1063.
7. Raivio T, Korponay-Szabo IR, Paajanen T, et al. Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assays. J Pediatr Gastroenterol Nutr 2008; 47(5): 562-;567.
8. Korponay-Szabó IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 2007; 335(7632): 1244-;1247.
9. Baviera LC, Aliaga ED, Ortigosa L, et al. Celiac disease screening by immunochromatographic visual assays: results of a multicenter study. J Pediatr Gastroenterol Nutr 2007; 45(5): 546-;550.
10. Violato M, Gray A, Papanicolas I, Ouellet M. Resource use and costs associated with coeliac disease before and after diagnosis in 3646 cases: results of a UK primary care database analysis. PLoS One 2012; 7(7): e41308.
11. Green PH, Neugut AI, Naiyer AJ, et al. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. J Insur Med 2008; 40(3-;4): 218-;228.
12. Long KH, Rubio-Tapia A, Wagie AE, et al. The economics of coeliac disease: a populationbased study. Aliment Pharmacol Ther 2010; 32(2): 261-;269.